Which Patients Benefit Most From Repeat PSA Testing?

/ Clinical Practice / /

TOPLINE: In a study involving more than 11,000 men enrolled in the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial, about one quarter of elevated prostate-specific antigen (PSA) results (≥ 2.5, 3.0, or 4.0 ng/mL) dropped below biopsy threshold the following year. More than half of men with at least one elevated result had […]

Which Patients Benefit Most From Repeat PSA Testing? Read More »